US Food and Drug Administration Commissioner Robert Califf offered subtle hints at a recent National Institutes of Health meeting that the agency may eventually try to curtail long-term opioid use through drug labeling.
“It’s well known that we’re looking closely at the labeling of chronic opioids at this point,” Califf said 22 February...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?